Advanced Oncotherapy plc (LON:AVO – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares changing hands.
Advanced Oncotherapy Stock Down 9.1 %
The firm has a market capitalization of £9.49 million, a PE ratio of -25.00 and a beta of 0.06. The company has a fifty day simple moving average of GBX 1.75 and a two-hundred day simple moving average of GBX 1.75. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- Investing in Commodities: What Are They? How to Invest in Them
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Using the MarketBeat Stock Split Calculator
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Canadian Penny Stocks: Can They Make You Rich?
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
